Cancer Research SABCS  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 43, 3563-3566, August 1, 1983]
© 1983 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehrer, R. I.
Right arrow Articles by Koeffler, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehrer, R. I.
Right arrow Articles by Koeffler, H. P.

Specific Binding of [3H]Phorbol Dibutyrate to Phorbol Diesterresponsive and -resistant Clones of a Human Myeloid Leukemia (KG-1) Line 1

Robert I. Lehrer1, Lenore E. Cohen and H. Phillip Koeffler2

Division of Hematology/Oncology, Department of Medicine, University of California at Los Angeles School of Medicine, Los Angeles, California 90024

Phorbol diesters induce macrophage-like differentiation in KG-1 and HL-60 human acute myelogenous leukemia cell lines. We developed a cloned subline of KG-1, known as KG-1a, that does not differentiate when exposed to phorbol diesters. Both KG-1 and KG-1a cells have a single class of specific high-affinity receptors for labeled phorbol-12,13-dibutyrate with a mean Kd of 1.47 ± 0.10 (S.E.) x 10-8 M and 0.85 ± 0.20 x 10-8 M for the sensitive parental KG-1 line and the resistant KG-1a subline, respectively (p < 0.025). The number of [3H]phorbol-12,13-dibutyrate binding sites (mean ± S.E.) per cell was 3.85 ± 0.98 x 105 and 3.94 ± 0.31 x 105 on KG-1 and resistant KG-1a cells, respectively. We observed no significant decrease of specific binding with time (down regulation) in either KG-1, KG-1a, or HL-60 cells, suggesting that down regulation of specific phorbol-12,13-dibutyrate binding is not critical to induction of differentiation. Our data also confirm that the presence of specific highaffinity phorbol receptors on leukemic cells does not assure that phorbol diesters can trigger their differentiation.

1 Recipient of grants from the NIH (CA 30526) and the USPHS. To whom requests for reprints should be addressed, at Division of Hematology/Oncology, Department of Medicine, 37-068 CHS, Los Angeles, Calif. 90024.

2 Recipient of support from the NIH (Grants CA 26038 and CA 32737); the Leukemia Society of America, Inc.; the Bruce Fowler, Jr., Memorial Fund; and the Jonsson Comprehensive Cancer Center. Scholar of the Leukemia Society of America.

Received 9/29/82. Accepted 5/ 3/83.




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. C. St. Louis, J. B. Woodcock, G. Fransozo, P. J. Blair, L. M. Carlson, M. Murillo, M. R. Wells, A. J. Williams, D. S. Smoot, S. Kaushal, et al.
Evidence for Distinct Intracellular Signaling Pathways in CD34+ Progenitor to Dendritic Cell Differentiation from a Human Cell Line Model
J. Immunol., March 15, 1999; 162(6): 3237 - 3248.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1983 by the American Association for Cancer Research.